Widening Racial and Sociodemographic Disparities in Cardiovascular Disease Death Counts in the United States: A Comprehensive Analysis of 2018-2023 National Data

P. P. Gupta, Vatsalkumar Jetani, Hardik Dineshbhai Desai, Sumit Kyada, Shivani B Sonani, Gokul Gopi, Sourya Acharya, Yash Vardhan Trivedi, Sandeep Kotnani, Hardik JainCureus 2025 · DOI

TL;DR

Cardiovascular disease (CVD) deaths are on the rise in the US, reversing decades of decline, and the increase is disproportionately affecting minority groups, younger adults, women, rural populations, and those with lower educational attainment. This study provides a detailed, disaggregated analysis of national mortality data from 2018-2023, highlighting urgent needs for targeted, equity-focused interventions.

What Problem Does This Paper Address?

For decades, the United States saw a decline in cardiovascular disease (CVD) mortality, a positive trend attributed to advancements in prevention and treatment. However, recent years have shown a concerning stall, and in some demographics, a reversal of this progress. This reversal is particularly troubling as it appears to be exacerbating existing disparities across various societal groups. The COVID-19 pandemic is also suspected to have played a role in this negative shift, potentially by disrupting healthcare access and exacerbating pre-existing inequities. This paper aims to comprehensively analyze recent trends in CVD mortality, specifically focusing on how these trends are widening disparities across a granular level of racial subgroups, sex, age, geography, and socioeconomic status, using the most recent available national data.

Methods

The researchers conducted a retrospective, population-based trend analysis using national mortality data from the National Vital Statistics System (NVSS) for the years 2018-2023. They accessed this data through the CDC's WONDER database. The core of their analysis involved calculating the Annualized Percentage Change (APC) in CVD deaths. To do this, they employed a log-linear regression model, regressing the natural logarithm of annual deaths against the calendar year. The slope coefficient from this regression was then transformed into the APC. This method allows for the quantification of the average annual rate of change in mortality counts. Crucially, the study stratified these analyses by a detailed set of demographic and socioeconomic factors, including 15 single-race categories, sex, Hispanic origin, 10-year age groups, census region, 2013 urbanization level, and educational attainment. They also performed cause-specific analyses for major ICD-coded CVD subcategories.

Datasets

The primary dataset used in this study is the National Vital Statistics System (NVSS) mortality data for the years 2018-2023, accessed via the Centers for Disease Control and Prevention's (CDC) Wide-ranging ONline Data for Epidemiologic Research (WONDER) online database. This dataset comprises Multiple Cause of Death Files compiled from 57 U.S. jurisdictions. The study did not introduce any new benchmarks; rather, it utilized existing national mortality data.

Key Insights and Ideas

  • Reversal of Progress: The most striking insight is the clear reversal of decades of declining CVD mortality. This isn't just a plateau; it's an upward trend, which is a significant public health concern.
  • Disaggregation is Key: The study's strength lies in its granular analysis. By breaking down data by 15 single-race categories, they reveal heterogeneity within broader racial groups that is often missed in aggregated statistics. This highlights that "Asian" or "Pacific Islander" are not monolithic categories when it comes to health outcomes.
  • Intersectionality Matters: The findings strongly suggest that multiple factors (race, sex, geography, education) interact to create compounded disadvantages. For instance, Hispanic subgroups within minority populations or individuals in rural areas with lower education face a particularly steep increase in CVD mortality.
  • Early Onset Concerns: The accelerated rise in CVD deaths among younger adults (25-44 years) is a critical warning sign, suggesting that the burden of chronic disease is shifting to earlier life stages, with potential long-term impacts on health and productivity.

Key Results

  • Overall Increase: Between 2018 and 2023, there were 5.4 million CVD deaths nationwide, with annual deaths increasing from 868,662 in 2018 to 915,973 in 2023.
  • Racial Disparities: The steepest increases in CVD mortality were observed in Other Pacific Islanders (6.67%/year), Vietnamese (6.16%/year), and Asian Indians (6.07%/year). In contrast, White individuals (1.17%/year) and Japanese (0.31%/year) showed minimal changes.
  • Geographic Disparities: The South and West regions experienced the most pronounced increases. Rural non-core areas showed the fastest growth in CVD deaths, with APCs above 5% among minority groups.
  • Age Disparities: While absolute mortality remained highest in older adults (≥65 years), the relative increases were largest in younger adults (25-44 years), with Black, Asian Indian, and American Indian groups showing APCs exceeding 5%.
  • Sex Disparities: Women generally experienced higher APCs than men across several racial groups.
  • Educational Disparities: Individuals with high school or lower levels of education consistently showed significantly higher APCs (two to three times higher) compared to college graduates.

Limitations and Future Work

The authors acknowledge several limitations:

  • Reliance on Death Certificates: The data is based on death certificates, which may have inaccuracies or residual confounding.
  • Crude Death Counts: The analysis used crude death counts rather than age-standardized rates, which could be modestly influenced by demographic shifts. This was necessary due to the unavailability of reliable population denominators for all disaggregated groups in the most recent year.
  • Unmeasured Variables: Potential residual confounding from unmeasured socioeconomic and behavioral variables exists.
  • COVID-19 Impact: The COVID-19 pandemic's influence on healthcare access, mortality certification, and direct biological effects is acknowledged as a potential confounder that is difficult to fully disentangle.

Future work should focus on developing and implementing targeted, equity-focused public health and clinical strategies. These strategies need to address the intersecting racial, geographic, and socioeconomic disadvantages that are driving these widening cardiovascular disparities. Further research could explore the specific mechanisms behind these trends, particularly the impact of the COVID-19 pandemic on CVD mortality and the long-term implications of rising premature CVD.

Summary updated

Abstract

Introduction Cardiovascular disease (CVD) remains the leading cause of death in the United States, yet recent trends suggest widening disparities across race, sex, geography, and socioeconomic groups. Methods We conducted a retrospective, population-based trend analysis of mortality data from the National Vital Statistics System (NVSS), 2018-2023, accessed via the Centers for Disease Control and Prevention (CDC) Wide-ranging ONline Data for Epidemiologic Research (WONDER) online Database. Deaths with CVD (International Classification of Diseases, 10th revision (ICD-10): I00-I99) as the underlying cause were included. Mortality counts were stratified by race (15 single-race categories), sex, age, census region, 2013 urbanization level, Hispanic origin, and education. Cause-specific analyses covered major ICD-coded CVD subcategories. Annualized percentage change (APC) and 95% confidence intervals (CI) were estimated using log-linear regression of annual counts. Results Between 2018 and 2023, there were 5.4 million CVD deaths nationwide, rising from 868,662 in 2018 to 915,973 in 2023. The steepest increases occurred in Pacific Islander (6.7%/year), Vietnamese (6.2%), and Asian Indian (6.1%) populations, while Whites individuals (1.2%) and Japanese (0.3%) showed minimal changes. By cause, ischemic and hypertensive heart diseases accounted for the largest gains. Regional increases were most pronounced in the South and West, and rural non-core areas exhibited the fastest growth. Younger adults (25-44 years) in Black individuals, Asian Indian, and American Indian groups showed APCs exceeding 5%. Women generally experienced higher APCs than men. Disparities were amplified by Hispanic origin and lower educational attainment. Conclusions CVD mortality in the United States is once again rising, with young adults, women, minority populations, rural residents, Hispanics, and the less educated experiencing the sharpest increases. These findings reveal a reversal of prior gains and underscore the urgent need for equity-focused prevention and policy strategies.
BibTeX
@inproceedings{gupta2025widening,
  author = {P. P. Gupta and Vatsalkumar Jetani and Hardik Dineshbhai Desai and Sumit Kyada and Shivani B Sonani and Gokul Gopi and Sourya Acharya and Yash Vardhan Trivedi and Sandeep Kotnani and Hardik Jain},
  title = {{Widening Racial and Sociodemographic Disparities in Cardiovascular Disease Death Counts in the United States: A Comprehensive Analysis of 2018-2023 National Data}},
  booktitle = {Cureus},
  year = {2025},
  doi = {10.7759/cureus.95210},
}
Figure